Concentrations of Selected PFAS Up in Firefighters After 2023 Maui Wildfires
Firefighters had higher serum concentrations of some PFAS than employees from other occupations, but mainly below threshold for screening
Opportunistic Salpingectomy During Any Abdominal Surgery Reduces Ovarian Cancer Risk
Implementing opportunistic salpingectomy would lead to health care cost savings
Immunogenic Cancer Vaccine Targets Key Mutations in Kidney Cancer
Personalized vaccine targets key driver mutations and induces antitumor immunity in fully resected high-risk clear cell renal cell carcinoma
Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer
Adding nivolumab to neoadjuvant chemotherapy significantly increases pathological complete response rates
Preterm Birth Slightly Higher for Offspring of Young Male Patients With Cancer
Prevalence of preterm birth and low birth weight slightly higher, but no difference seen in prevalence of birth defects
Four in 10 Patients Receiving Chemo Develop Chronic Painful Neuropathy
Among patients with chemotherapy-induced peripheral neuropathy, those treated with platinum-based agents, taxanes had highest prevalence
Dual-Targeted Therapies Plus Chemo Improve Objective Response Rate in BRAF V600E Metastatic CRC
Significant and clinically relevant improvement seen in objective response rate with encorafenib + cetuximab plus mFOLFOX6
Improvements in Prostate Cancer Mortality Plateaued From 2012 to 2021
At the same time, incidence of distant-stage prostate cancer increased
Blood Test May Provide New Option for Colorectal Cancer Screening
U.S. Census sex-age adjustments improved clinical performance estimates
FDA Approval Expands Earlier Use of Enhertu for Metastatic Breast Cancer
Approval is targeted for patients with HER2-low or HER2-ultralow metastatic breast cancer with disease progression after endocrine therapy
